www.fgks.org   »   [go: up one dir, main page]

WHO Expert Committee on Drug Dependence: Difference between revisions

Content deleted Content added
Add list of substances under surveillance
 
(18 intermediate revisions by 6 users not shown)
Line 4:
| established = 1948
| mission = Conducting the medical and scientific evaluation of drugs
| website = [https://www.who.int/groups/who-expert-committee-on-drug-dependence#:~:text=The%20WHO%20Expert%20Committee%20on%20Drug%20Dependence%20(ECDD)%20consists%20of,recommendations%20to%20the%20international%20community. ECDD Website ]
| num_members = 11{{efn| As of 2023, number of members were counted by the amount of individuals within the document. See reference 1.}}
| num_members = 11
}}
The '''WHO Expert Committee on Drug Dependence (ECDD)''' is a committee within the [[World Health Organization|World Health Organisation]] (WHO) that consists of a chosen group of independent experts within the field of [[pharmacology]]. This committee meets once a year in order to evaluate the effects of psychotic{{efn|Refers to psychoative substances}} substances towards the public and the properties that cause the addictions, and considering the possible medical or therapeutic benefits and applications.<ref>{{cite web |title=46th ECDD Committee Member Biographies |url=https://cdn.who.int/media/docs/default-source/46th-ecdd/46th-ecdd-biographies.pdf?sfvrsn=344c8b03_3 |publisher=WHO}}</ref>
 
== Committee Membersmembers ==
The committee is composed of different specialists (the number can vary) who are experts within the field of drugs and medicines. This list is updated alongside the 2023 46th ECDD Committee Member List:<ref>{{cite web |title=The WHO Expert Committee on Drug Dependence (ECDD) |url=https://www.who.int/groups/who-expert-committee-on-drug-dependence#:~:text=The%20WHO%20Expert%20Committee%20on%20Drug%20Dependence%20(ECDD)%20consists%20of,recommendations%20to%20the%20international%20community. |publisher=WHO |date=2023}}</ref>
 
* Prof. Patrick Beardsley
Line 25:
* Suti Nudmamud Thanoi
 
==Meetings==
Due to the large amounts of meetings in the ECDD, this list will only go as far to the 45th Committee Meeting.
 
'''46th Expert Committee on Drug Dependence Meeting'''<ref>{{cite web |title=46th Expert Committee on Drug Dependence documents |url=https://www.who.int/groups/who-expert-committee-on-drug-dependence/46th-ecdd-documents |website=Expert Committee on Drug Dependence |publisher=WHO (ECDD)}}</ref>
was held on 16th October 2023, and reviewed 8 different drugs, such as: Benzodiazepines such as [[Bromazolam]] and [[Flubromazepam]], Novel synthetic [[Opioid|opioids]]{{efn|Novel Synthetic Opoids refers to new opoids that were synthesised within laboratories or equivalent.}} such as [[Butonitazene]], [[Substituted cathinone|Cathinones]]/[[Stimulant|stimulants]] such as [[3-Chloromethcathinone|3-CMC]] and [[Dipentylone]], Dissociative-type substances such as [[2-Fluorodeschloroketamine|2-fluorodeschloroketamine]] as well as medicines such as [[Nitrous oxide (medication)|Nitrous Oxide (medication)]] and [[Carisoprodol]].
 
'''45th Expert Committee on Drug Dependence Meeting'''<ref>{{cite web |title=Expert Committee on Drug Dependence |url=https://www.who.int/groups/who-expert-committee-on-drug-dependence/45th-ecdd-documents |website=45th Expert Committee on Drug Dependence documents |publisher=WHO (ECDD)}}</ref>
45th Expert Committee on Drug Dependence Meeting was held on the 10th of October 2022, and reviewed 9 different drugs such as: [[Cannabinoid|Cannabinoids]] such as [[ADB-BUTINACA]],
[[Benzodiazepine|Benzodiazepines]] such as [[Adinazolam]] and [[Bromazolam]], [[Opioid|syntetic opioids]] such as [[Protonitazene]], [[Etodesnitazene]], [[etonitazene|N-pyrrolidino etonitazene)]] and [[2-Methyl-AP-237]], Stimulants such as: [[Alpha-Pyrrolidinohexiophenone|alpha-PiHP]] and 3[[3-Methylmethcathinone|-Methylmethcathinone (3-MMC)]] and medicines such as [[Zopiclone]].
 
==Substances under watchlist==
The ECDD currently have 25 drugs under their watchlist as of 2023,<ref>{{cite web |title=LIST OF SUBSTANCES UNDER SURVEILLANCE 2023 |url=https://cdn.who.int/media/docs/default-source/46th-ecdd/2023_who_substances-under-surveillance.pdf?sfvrsn=7cdb47e6_1 |publisher=WHO ECDD}}</ref> split into 7 different cateogories:
 
[[Amphetamine type stimulant|Amphetamine-type stimulants]]:
 
* [[5-APB]]
* [[5-MAPB]]
* [[2-DPMP]]
* [[MDAI]]
 
[[Benzodiazepine|Benzodiazepines]]:
 
* [[Adinazolam]]
* [[Bromazolam]]
 
[[Cannabinoid|Synthetic Cannabinoid Receptor Agonists]]:
 
* [[4F-MDMB-BICA]]
* [[APINACA]]
* [[RCS-4]]
* [[JWH-250]]
* [[JWH-073]]
 
[[Substituted cathinone|Synthetic cathinones]]:
 
* [[4-Fluoromethcathinone]]
* [[Benzylone]]
 
[[Opioid|Opioids]]:
 
* [[Para-methoxybutyryl fentanyl]]
* [[Parafluorofuranylfentanyl]]
* [[Kratom]] / [[mitragynine]] / [[7-Hydroxymitragynine]]
 
[[Substituted tryptamine|Tryptamines]]:
 
* [[Alpha-methyltryptamine]]
 
[[Psychoactive drug|Psychoactive Medicines]]:
 
* [[Gabapentin]]
* [[Ketamine]]
* [[Phenibut]]
* [[Pregabalin]]
* [[Tapentadol]]
* [[Tramadol]]
* [[Zaleplon]]
* [[Zopiclone]]
 
==See also==
* [[World Health Organization]]
* [[Drugs]]
 
==Notes==
{{notelist}}
==References==
{{reflist}}
 
[[Category:World Health Organization]]
[[Category:Drug policy organizations]]